---
title: "礼来公司（LLY）获得了花旗银行的买入评级"
description: "Meacham 涉及医疗保健行业，关注的股票包括礼来公司、安进和 Vertex Pharmaceuticals。根据 TipRanks 的数据，Meacham 推荐股票的平均回报率为 4.2%，成功率为 55.14%。除了花旗集团，礼来公司还在 10 月 10 日的报告中获得了富国银行的 Mohit Bansal 的买入评级。然而，汇丰银行在 10 月 1 日对礼来公司（纽约证券交易所代码：LLY"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/260882061.md"
published_at: "2025-10-13T10:55:53.000Z"
---

# 礼来公司（LLY）获得了花旗银行的买入评级

> Meacham 涉及医疗保健行业，关注的股票包括礼来公司、安进和 Vertex Pharmaceuticals。根据 TipRanks 的数据，Meacham 推荐股票的平均回报率为 4.2%，成功率为 55.14%。除了花旗集团，礼来公司还在 10 月 10 日的报告中获得了富国银行的 Mohit Bansal 的买入评级。然而，汇丰银行在 10 月 1 日对礼来公司（纽约证券交易所代码：LLY）维持了持有评级

Meacham 关注医疗保健行业，重点分析如礼来公司、安进和 Vertex Pharmaceuticals 等股票。根据 TipRanks 的数据，Meacham 推荐股票的平均回报率为 4.2%，成功率为 55.14%。

除了花旗，礼来公司还在 10 月 10 日的报告中获得了富国银行的 Mohit Bansal 的买入评级。然而，在 10 月 1 日，汇丰维持了对礼来公司（纽约证券交易所代码：LLY）的持有评级。

### Related Stocks

- [LLY.US - 礼来](https://longbridge.com/zh-CN/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Eli Lilly and Company $LLY Shares Acquired by Assetmark Inc. | Assetmark Inc. increased its holdings in Eli Lilly and Company (NYSE: LLY) by 6.0% in Q3, owning 55,360 shares valued at | [Link](https://longbridge.com/zh-CN/news/275971336.md) |
| Eli Lilly Stock (LLY) Rises on Plan to Invest $1 Billion in India | Eli Lilly's stock (LLY) rose approximately 1% following the announcement of a $1 billion investment in India to enhance  | [Link](https://longbridge.com/zh-CN/news/276152620.md) |
| Jim Cramer discusses Eli Lilly (LLY) & weight loss drugs | Jim Cramer recently discussed Eli Lilly and Company (NYSE:LLY), which has seen its shares rise by 23.5% over the past ye | [Link](https://longbridge.com/zh-CN/news/276258256.md) |
| Eli Lilly and Company $LLY Shares Bought by Balentine LLC | Balentine LLC increased its stake in Eli Lilly and Company (NYSE: LLY) by 150.1% in Q3, owning 4,042 shares valued at $3 | [Link](https://longbridge.com/zh-CN/news/276105002.md) |
| Eli Lilly (LLY) Builds $1.5 Billion Inventory of Weight-Loss Pill | Eli Lilly (LLY) has prepared a $1.5 billion inventory of its new weight-loss pill, Orforglipron, ahead of its anticipate | [Link](https://longbridge.com/zh-CN/news/276070062.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。